Clinical trial · Observational
Sentinel Lymph Nodes Biopsy in Cervical Cancer
Sentinel Lymph Nodes Biopsy Versus Lymphadenectomy in Cervical Cancer
NCT06169787CI-TRIAL-00078005unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to compare sentinel lymph nodes biopsy versus comprehensive lymphadenectomy in patients with early stage cervical cancer who underwent radical hysterectomy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Sentinel Lymph Node | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| comprehensive pelvic lymphadenectomy | Procedure | — | UNRESOLVED |
| sentinel lymph node biopsy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Sentinel Lymph Node
- description
- Sentinel lymph node biopsy in patients with early stage cervical cancer
- interventionNames
- Procedure: sentinel lymph node biopsy
- label
- Lymphadenectomy
- description
- Comprehensive lymphadenectomy in patients with early stage cervical cancer
- interventionNames
- Procedure: comprehensive pelvic lymphadenectomy
Primary outcomes (1)
- measure
- progression free survival
- timeFrame
- 5 years
- description
- progression free survival between these two groups
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: Women aged 20 and above with clinical FIGO stage I-IIA cervical cancer Exclusion Criteria: Women did not receive surgical treatment
References
Publications (0)
Data not yet available
No reference posted for this study.